Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 68084-313

7 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68084-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ahp31301

Ahp31301
Divalproex Sodium 125 mg capsule, coated pellets, shown with a distinctive two-tone blue and white design. The capsule is marked with partial black printed text including the dose strength and identification codes. The image shows the capsule dosage form clearly, consistent with oral administration.*
FDA Label Image

Figure 1

Figure 1
A cumulative distribution plot showing the percentage reduction in CPS rate for patients treated with Divalproex Sodium Delayed-release Tablets compared to placebo. The x-axis represents the percentage of patients, while the y-axis shows the percentage reduction in CPS rate. The graph compares treatment improvement and worsening between the two groups.*
FDA Label Image

Figure 2

Figure 2
A line chart showing the percent reduction in CPS Rate plotted against the percent of patients, with two lines comparing High Dose (solid line) and Low Dose (dashed line). The chart includes labels indicating 'Improvement' above and 'Worsening' below, with a 'No Change' line at 0% reduction.*
FDA Label Image

Guide

Guide
An instructional illustration showing how to open a Divalproex Sodium 125 mg coated pellet capsule and sprinkle its contents onto soft food for oral administration. The series includes images demonstrating careful capsule opening, sprinkling pellets onto food like applesauce or pudding, and consuming the mixture immediately without chewing.*
FDA Label Image

Structure

Structure
Chemical structure of divalproex sodium showing the polymeric form with sodium ions and multiple valproic acid units linked.*
FDA Label Image

Image 02

Image 02
Divalproex Sodium 125 mg delayed-release capsules label showing dosage form as capsules with coated pellets. The label indicates 100 capsules per package (10 blister packs of 10 capsules each). It specifies the active ingredient as Divalproex sodium in delayed-release form, marketed by American Health Packaging, with NDC 68084-313-01. The label includes pharmacist dispensing instructions and storage temperature guidelines.*
FDA Label Image

Structured Product Formula For Divalproex (Image 03)

Structured Product Formula For Divalproex (Image 03)
Divalproex Sodium 125 mg delayed-release capsule labels from American Health Packaging, Columbus, Ohio. Each label includes the drug name, strength (125 mg), dosage form, barcodes, and spaces for expiration date and lot number. The labels are arranged in pairs on the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.